Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.61 |
| ▸ | CA2 | P00918 | 5/20 | 0.61 |
| ▸ | CA12 | O43570 | 4/20 | 0.61 |
| ▸ | CA9 | Q16790 | 4/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.61 |
| ▸ | CA3 | P07451 | 3/20 | 0.61 |
| ▸ | CA4 | P22748 | 3/20 | 0.61 |
| ▸ | CA6 | P23280 | 3/20 | 0.61 |
| ▸ | CA5A | P35218 | 3/20 | 0.61 |
| ▸ | CA7 | P43166 | 3/20 | 0.61 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.61 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.61 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.56 |
| ▸ | MMP1 | P03956 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | MMP9 | P14780 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL177792 | 0.88 | HSPB1 (0.59) | CA1CA2CA12CA9CA14 | |
| Monoethanolamine SCHEMBL10485204 | 0.85 | KCNJ1 (0.52) | CA1CA2CA12CA9CA14 | |
| SCHEMBL22495982 | 0.84 | SIRT6 (0.68) | KCNJ1KCNH2ALDH1A1 | |
| SCHEMBL10485257 | 0.84 | CA1 (0.51) | CA1CA2CA12CA9CA14 | |
| SCHEMBL29382330 | 0.82 | CA2 (0.57) | CA1CA2CA12CA9CA14 | |
| SCHEMBL486719 | 0.82 | CA2 (0.57) | CA1CA2CA12CA9CA14 | |
| SCHEMBL17645102 | 0.82 | CA2 (0.57) | CA1CA2CA12CA9CA14 | |
| SCHEMBL30542225 | 0.81 | ALDH1A1 (0.67) | CA1CA2CA9PTGS2FAAH | |
| SCHEMBL5088269 | 0.81 | ALDH1A1 (0.56) | CA1CA2CA12CA9CA14 | |
| Iodomethane SCHEMBL10485500 | 0.81 | CA1 (0.49) | CA1CA2CA12CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101704950-B | PASSI terpolymer and preparation method thereof | NINGBO INST MAT TECH & ENG CAS | 2013-07-31 | — | — | CN | claimed |
| EP-2233512-B1 | POLYTHIOETHERIMIDES AND METHOD FOR PRODUCING THEREOF | NINGBO INST MATERIALS TECHNOLOGY & ENG CAS (CN) | 2013-03-20 | — | — | EP | claimed |
| CN-102030903-B | Preparation method of polythioether ketone imide terpolymer | NINGBO INST MAT TECH & ENG CAS | 2013-03-06 | — | — | CN | claimed |
| CN-102030903-A | Polythioether ketone imide terpolymer and preparation method thereof | NINGBO INST MAT TECH & ENG CAS | 2011-04-27 | — | — | CN | claimed |
| US-20110065891-A1 | POLYTHIOETHERIMIDES AND METHOD FOR PRODUCING THEREOF | CHANGCHUN HIPOLYKING CO.,LTD. (CN) | 2011-03-17 | — | — | US | claimed |
| EP-2233512-A1 | POLYTHIOETHERIMIDES AND METHOD FOR PRODUCING THEREOF | Ningbo Institute Of Materials Technology And Engineering, Chinese Academy Of Sciences (CN) | 2010-09-29 | — | — | EP | claimed |
| CN-101704950-A | PASSI terpolymer and preparation method thereof | NINGBO INST MAT TECH & ENG CAS | 2010-05-12 | — | — | CN | claimed |
| CN-101531758-A | Polythioetherimide and preparation method thereof | NINGBO INST MAT TECH & ENG CAS | 2009-09-16 | — | — | CN | claimed |
| US-20240400591-A1 | COMPOUNDS TARGETING MUTANT OF P53 | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2024-12-05 | — | — | US | disclosed |
| WO-2024175450-A1 | SUBSTITUTED S-ALANINATE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-08-29 | — | — | WO | disclosed |
| EP-4384510-A1 | COMPOUNDS TARGETING MUTANT OF P53 | Jacobio Pharmaceuticals Co., Ltd. (CN) | 2024-06-19 | — | — | EP | disclosed |
| CN-115772105-B | Synthesis method of 4-nitroanisole | 厦门大学 | 2024-06-11 | — | — | CN | disclosed |
| WO-2024105057-A1 | DATA ANALYSIS METHOD FOR MULTIPLEX DIGITAL PCR USING COLOR-COMBINATION | STILLA TECHNOLOGIES (FR) | 2024-05-23 | — | — | WO | disclosed |
| WO-2024094817-A1 | A PREDICTIVE SCORE OF CANCER IMMUNOTHERAPY OUTCOME BASED ON ECOLOGICAL ANALYSIS OF GUT MICROBIOTA | INSTITUT GUSTAVE ROUSSY (FR) | 2024-05-10 | — | — | WO | disclosed |
| WO-1996025936-A1 | 2,6-DIARYL PYRIDAZINONES WITH IMMUNOSUPPRESSANT ACTIVITY | MERCK & CO., INC. (US) | 1996-08-29 | — | — | WO | disclosed |
| WO-1996003388-A1 | 1,2-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-02-08 | — | — | WO | disclosed |
| EP-0039312-B1 | COLOUR PHOTOPGRAPHIC MATERIAL FOR THE SILVER-DYE BLEACHING PROCESS, PROCESS FOR THE PRODUCTION OF THIS MATERIAL AND ITS USE IN THE PRODUCTION OF PHOTOGRAPHIC IMAGES | CIBA-GEIGY AG (CH) | 1983-12-28 | — | — | EP | disclosed |
| US-4379819-A | OIL SOLUBLE MONOAZO DYE | CIBA-GEIGY AG (CH) | 1983-04-12 | — | — | US | disclosed |
| EP-0051773-A1 | Penicillins, their salts, process for their preparation and pharmaceutical compositions containing them | Dr. Karl Thomae GmbH (DE) | 1982-05-19 | — | — | EP | disclosed |
| EP-0039312-A1 | Colour photopgraphic material for the silver-dye bleaching process, process for the production of this material and its use in the production of photographic images | CIBA-GEIGY AG (CH) | 1981-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400591-A1 | COMPOUNDS TARGETING MUTANT OF P53 | TP53, TP53BP1, MDM2 | CA1 2782/4885CA2 3601/4885CA12 3295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.